WHO ICTRP trial
Fecal microbiota transfer for the secondary prevention of recurrent urinary…
CTIS2025-520452-28-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2025-520452-28-00 |
|---|---|
| Public title | Fecal microbiota transfer for the secondary prevention of recurrent urinary tract infections in premenopausal women: a phase II trial (FEMITRANS) |
| Scientific title | Fecal microbiota transfer for the secondary prevention of recurrent urinary tract infections in premenopausal women: a phase II trial (FEMITRANS) - FEMITRANS |
| Primary sponsor | Goethe University Frankfurt |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Germany |
| Conditions | Recurrent urinary tract infections (rUTI);Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01] |
| Interventions | Product Name: MOVIPREP, Pulver zur Herstellung einer Lösung zum Einnehmen, Product Code:PRD324629, Pharmaceutical Form: ORAL SOLUTION, Other descriptive name: , Strength: , Product Name: VANCOMYCIN, Product Code:SUB05076MIG, Pharmaceutical… |
| Registration date | Mar 24, 2025 |
| Target size | 24 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: